Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sebastian Debus

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Journal of the American Heart Association|June 14, 2022
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Iris Baumgartner, Sonia S Anand, et al.
Trials|September 20, 2021
ACTION-1: study protocol for a randomised controlled trial on ACT-guided heparinization during open abdominal aortic aneurysm repairArno M Wiersema, Liliane C Roosendaal, Mark J W Koelemaij, et al.
Journal of the American College of Cardiology|August 21, 2024
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity RevascularizationMario Enrico Canonico, Cecilia C Low Wang, Judith Hsia, et al.
Circulation. Cardiovascular Interventions|February 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD TrialMario Enrico Canonico, Jessica Parr, E Sebastian Debus, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 2, 2020
Editor's Choice - International Variations and Sex Disparities in the Treatment of Peripheral Arterial Occlusive Disease: A Report from VASCUNET and the International Consortium of Vascular RegistriesChristian-Alexander Behrendt, Birgitta Sigvant, Jenny Kuchenbecker, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2022
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy aloneScott D Berkowitz, Rupert M Bauersachs, Michael Szarek, et al.
Cardiovascular Diagnosis and Therapy|January 6, 2018
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)Yskert von Kodolitsch, Oliver Wilson, Helke Schüler, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 26, 2021
Contralateral Stenosis and Echolucent Plaque Morphology are Associated with Elevated Stroke Risk in Patients Treated with Asymptomatic Carotid Artery Stenosis within a Controlled Clinical Trial (SPACE-2)Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
The Lancet. Neurology|September 17, 2022
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trialTilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Journal of the American Heart Association|June 14, 2022
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Iris Baumgartner, Sonia S Anand, et al.
Trials|September 20, 2021
ACTION-1: study protocol for a randomised controlled trial on ACT-guided heparinization during open abdominal aortic aneurysm repairArno M Wiersema, Liliane C Roosendaal, Mark J W Koelemaij, et al.
Journal of the American College of Cardiology|August 21, 2024
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity RevascularizationMario Enrico Canonico, Cecilia C Low Wang, Judith Hsia, et al.
Circulation. Cardiovascular Interventions|February 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD TrialMario Enrico Canonico, Jessica Parr, E Sebastian Debus, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 2, 2020
Editor's Choice - International Variations and Sex Disparities in the Treatment of Peripheral Arterial Occlusive Disease: A Report from VASCUNET and the International Consortium of Vascular RegistriesChristian-Alexander Behrendt, Birgitta Sigvant, Jenny Kuchenbecker, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2022
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy aloneScott D Berkowitz, Rupert M Bauersachs, Michael Szarek, et al.
Cardiovascular Diagnosis and Therapy|January 6, 2018
Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)Yskert von Kodolitsch, Oliver Wilson, Helke Schüler, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 26, 2021
Contralateral Stenosis and Echolucent Plaque Morphology are Associated with Elevated Stroke Risk in Patients Treated with Asymptomatic Carotid Artery Stenosis within a Controlled Clinical Trial (SPACE-2)Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
The Lancet. Neurology|September 17, 2022
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trialTilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Pageof 11